What To Expect From MediWound Ltd Q3 2024 Earnings

MDWD Stock  USD 17.45  0.55  3.25%   
About 54% of Mediwound's shareholders are presently thinking to get in. The analysis of overall sentiment of trading Mediwound stock suggests that some investors are interested at this time. The current market sentiment, together with Mediwound's historical and current headlines, can help investors time the market. In addition, many technical investors use Mediwound stock news signals to limit their universe of possible portfolio assets.
  
MediWound Ltd is set to release its Q3 2024 earnings on Nov 26, 2024. The consensus estimate for Q3 2024 revenue is 6.01 million, and the earnings are expected to come in at -0.45 per share. The full year 2024s revenue is expected to be 23.84 million and the earnings are expected to be -2.69 per share.

Read at finance.yahoo.com
Yahoo News
  

Mediwound Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Mediwound can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Mediwound Fundamental Analysis

We analyze Mediwound's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mediwound using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mediwound based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Number Of Employees

Number Of Employees Comparative Analysis

Mediwound is currently under evaluation in number of employees category among its peers. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.

Mediwound Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Mediwound stock to make a market-neutral strategy. Peer analysis of Mediwound could also be used in its relative valuation, which is a method of valuing Mediwound by comparing valuation metrics with similar companies.

Peers

Mediwound Related Equities

GLUEMonte Rosa   13.72   
0%
100.0%
SANASana Biotechnology   9.02   
0%
65.0%
GBIOGeneration Bio   6.29   
0%
45.0%
LYELLyell Immunopharma   3.26   
0%
23.0%
OCULOcular Therapeutix   3.18   
0%
23.0%
FHTXFoghorn Therapeutics   2.57   
0%
18.0%
SNDXSyndax Pharmaceuticals   1.27   
0%
9.0%
REPLReplimune   0.21   
0%
1.0%
VCYTVeracyte   0.14   
0%
1.0%
MRUSMerus BV   0.29   
2.0%
0%
AVTEAerovate Therapeutics   0.38   
2.0%
0%
SWTXSpringWorks Therapeutics   0.60   
4.0%
0%
RNAAvidity Biosciences   0.69   
5.0%
0%
CRNXCrinetics Pharmaceuticals   0.81   
5.0%
0%
KRONKronos Bio   1.04   
7.0%
0%
ELYMEliem Therapeutics   1.30   
9.0%
0%
KROSKeros Therapeutics   1.38   
10.0%
0%
STROSutro Biopharma   1.49   
10.0%
0%
INBXInhibrx   2.37   
17.0%
0%
MLYSMineralys Therapeutics,   2.59   
18.0%
0%
NKTXNkarta   4.01   
29.0%
0%
DYAIDyadic International   8.56   
62.0%
0%

Complementary Tools for Mediwound Stock analysis

When running Mediwound's price analysis, check to measure Mediwound's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mediwound is operating at the current time. Most of Mediwound's value examination focuses on studying past and present price action to predict the probability of Mediwound's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mediwound's price. Additionally, you may evaluate how the addition of Mediwound to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years